News
Aspivix raises 1.95 million euros via crowdfunding campaign
Aspivix, the Swiss start-up behind Carevix™, an innovative device designed to transform gynecological practices, recently launched a crowdfunding campaign that has already raised 1.9 million euros. The initiative aims to bring together a community committed to supporting a technology focused on women’s comfort and health. With 85 investors, the crowdfunding campaign, accessible on…
Read MoreDiverSsiTy SA: Therapy for Adolescents with Autism Spectrum Disorder (ASD)
DiverSsiTy SA leverages Mixed Reality (MR) and Artificial Intelligence (AI) to revolutionise mental health for people with Autism Spectrum Disorder (ASD). The company has developed a personalized therapeutic solution designed to enhance social, emotional, and proprioceptive skills in adolescents with high-functioning autism, ultimately improving their quality of life and social integration. Origins &…
Read MoreA CHF 2 Million Innosuisse Grant for Tune Insight
2025 is off to a groundbreaking start for Tune Insight, a leading EPFL spin-off specializing in privacy-preserving data collaboration solutions. The start-up secured a CHF 2 Million Innosuisse Grant to revolutionise Real-World Evidence (RWE) access for AI in pharma. Despite growing interest in using Real-World Evidence (RWE) to fuel AI innovation in healthcare, access…
Read MoreVandria starts clinical trials for VNA-318
Vandria SA, a Vaud-based start-up at the vanguard of mitochondrial therapeutics developing first-in-class small molecule mitophagy inducers, announced last December that the first subjects have been dosed in its first-in-human clinical trial of its lead Central Nervous System (CNS) compound VNA-318. Readout of this combined single and multiple ascending dose trial is expected in the…
Read MoreActival receives CHF 150’000 from Venture Kick to launch innovative dental aligners
The CSEM spin-off is launching its advanced Active Aligners to provide a more effective and healthier approach to orthodontic care. The Medtech startup was financed with CHF 150,000 by Venture Kick, winning the third stage of the program. Traditional clear aligners have transformed orthodontics, offering a discreet alternative to braces in a rapidly…
Read MoreONWARD Medical Secures FDA Approval for First Non-Invasive Spinal Cord Stimulation System
ONWARD Medical has reached a significant milestone in spinal cord injury (SCI) treatment, receiving FDA de novo classification and U.S. market authorization for its ARC-EX System. This innovative device is the first non-invasive technology approved to improve hand strength and sensation in individuals with chronic SCI, offering hope to a community often told recovery is…
Read MoreAstrocyte and MyoLink supported by FIF
Two Geneva-based life sciences projects have been selected to receive funding through the FONGIT Innovation Fund (FIF). Astrocyte and MyoLink, received a grant and a Seed Loan. MyoLink: Simplifying muscle monitoring for gait rehabilitation MyoLink is addressing unmet needs in gait rehabilitation with a non-invasive, easy-to-set-up system for real-time muscle monitoring. Current tools…
Read MoreNeuria obtains final Kick of CHF 150,000
The UNIFR spin-off created a digital health solution targeting overweight through neuroscience and is supported by Venture Kick. More than 2 billion adults worldwide suffer from overweight and associated chronic diseases, such as obesity and diabetes. This public health problem is compounded by the failure of 80% of traditional interventions. Neuria, a health technology…
Read MoreLimula, Actival and AirCurve supported by the FIT
Limula and its automation process for the production of cell therapies, Actival and its ‘active’ dental aligners, and AirCurve and its AI-guided robotic system for tracheal intubation, have all received Tech Loans from FIT. Limula: automating the production of cell therapies to make them more accessible to patients In the treatment of cancers…
Read MoreWyss Center invests CHF 750,000 in dEEGtal
The Wyss Center is proud to partner with dEEGtal Insight SA with a CHF 750,000 investment in its next stage of growth and development. dEEGtal Insight SA is a pioneering spin-off, of the Geneva University Hospitals (the EEG and Epilepsy Unit) and the University of Geneva, focused on transforming early detection and diagnosis of…
Read More